Pets Enhancing Therapeutics in Intensive Care Units

NCT07159568 · tracked via the Priya Life Science France tracker

Sponsor

University Hospital, Clermont-Ferrand

Phase

Not applicable

Started

2025-09-15

Last updated

2025-09-08

Condition(s) studied

Intensive Care Unit (ICU) PatientsDog Therapy

Investigational drug(s) / intervention(s)

Pet dog visit

Pet dog visit: Pet dog visit will take place during dedicated time slots, following prior verification of the dog's hygiene criteria. The dog may stay in the patient's room for a maximum of 15 minutes. After the visit, an evaluation questionnaire will be completed by the healthcare staff and by the relative who accompanied the dog. The patient's evaluation questionnaire will be completed at ICU discharge if patient is able to respond, or at most 28 days after inclusion if the patient remains in the ICU.

Study summary

Intensive Care Units (ICUs) are well known for their therapeutic and environmental aggressiveness. Current recommendations for the management of critically ill patients, including the "ABCDEF bundle," emphasize family engagement and liberal visitation policies for relatives and loved ones, with the aim of improving patient well-being during their ICU stay.

In France, half of all households own a pet. This close relationship between humans and animals explains why animals have long been involved in medical care. The earliest known use of animals in medicine dates back to the 9th century in Belgium, where they were used to assist individuals with mental illness. More recently, companion animal-assisted interventions have attracted growing interest due to their potential diagnostic and/or therapeutic value, as they may enhance the patient experience during hospitalization. The feasibility, safety, and potential benefits of pet visitation policies have mainly been assessed in conventional hospital wards, but remain understudied in the ICU setting. In France, to our knowledge, only three hospitals have allowed pet visits in the ICU, and these occurred outside of any research protocol.

The study primary objective is to assess the feasibility of companion dog visits in three medical-surgical ICUs.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Adult patient aged 18 years or older, * Admitted to one of the participating ICUs at Clermont-Ferrand University Hospital (Estaing Adult ICU, Montpied Medical-Surgical ICU, or Montpied Neuro-ICU) with an expected ICU stay of 48 hours or more, * Owner of a companion dog, with family members or relatives able to bring the dog to the ICU. Exclusion Criteria: Patient-related exclusion criteria: * Refusal by the patient or by their family/relatives to participate, * Lack of affiliation with the French national health insurance system (Sécurité Sociale), * Patient deprived of liberty or under legal protection (guardianship, curatorship, or judicial safeguard), * Pregnant or breastfeeding patient, * Agitated patient, defined as a Richmond Agitation-Sedation Scale (RASS) score \> 0 (monitored every four hours according to current standard practice), * Patient with immunosuppression, defined as: blood neutrophil count \< 0.5 G/L, ongoing or recent (within the past month) treatment for solid or hematologic cancer (e.g., chemotherapy, radiotherapy, cell therapy), or receiving immunosuppressive drugs (including organ transplant recipients or corticosteroid therapy for more than two weeks), * Patient with known colonization by multidrug-resistant bacteria (as routinely assessed upon ICU admission and weekly thereafter), * Patient with one or more open wounds or injuries that cannot be covered with a dressing. Dog-related exclusion criteria: * Dog belonging to category 1 or 2 breeds considered dangerous under current French regulations, * Dog that never leaves the home environment, * Dog with an incomplete vaccination status, * Dog with a known transmissible disease.

Primary outcome measure(s)

Success of the pet dog visit — Immediately after the intervention
The success of the pet dog visit is defined as the entry of the animal into the patient's ICU room under the conditions specified in the study protocol

Trial sites (1)

Facility	City	Region	Status
CHU Clermont-Ferrand	Clermont-Ferrand	France

More University Hospital, Clermont-Ferrand trials in France

Interest of an Attentional Evaluation by a Computerized Battery in the Management of Concussion in Young Rugby Players Recruiting

Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years Recruiting

CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke Recruiting

Evaluation of the Relationship Between Muscle Mass Measured by Bioelectrical Impedance Analysis and the Risk of Hemorrhagic Events Under Direct Oral Anticoagulants in the Elderly Starting soon

Preservation of Women's Fertility: Evaluation of Innovative Methods for Ovarian Tissue Cryopreservation Active, not recruiting

Other trials for the same condition

Study of Interactions Between Oncologists and Resuscitators to Optimize Decision Making for Admission of Patients With Metastatic Solid Cancer to the ICU (InterOncoRea) Active, not recruiting

Evaluation of the Clinical and Prognostic Value of Non-invasive Analysis of Mandibular Movements (MM) as a Marker of Inspiratory Effort in the Spontaneously Breathing Intensive Care Patient Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07159568 on ClinicalTrials.gov ↗ ← All trials in France